Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.075
-0.045 (-1.44%)
At close: Jul 17, 2026, 4:00 PM EDT
3.040
-0.035 (-1.14%)
After-hours: Jul 17, 2026, 4:54 PM EDT
Evaxion Revenue
Evaxion had revenue of $7.53M in the twelve months ending March 31, 2026, up 128.61% year-over-year. In the year 2025, Evaxion had annual revenue of $7.53M with 125.12% growth.
Revenue (ttm)
$7.53M
Revenue Growth
+128.61%
P/S Ratio
3.41
Revenue / Employee
$163,652
Employees
46
Market Cap
25.65M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.53M | 4.18M | 125.12% |
| Dec 31, 2024 | 3.34M | 3.27M | 4,480.82% |
| Dec 31, 2023 | 73.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 26.55M |
| Barinthus Biotherapeutics | 14.97M |
| Plus Therapeutics | 5.18M |
| IGC Pharma | 1.11M |
| VYNE Therapeutics | 454.00K |
| Actinium Pharmaceuticals | 90.00K |
EVAX News
- 2 days ago - Evaxion Biotech to present EVX-01 clinical efficacy data at ESMO - TheFly
- 2 days ago - Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026 - GlobeNewsWire
- 7 days ago - Evaxion Biotech presents new data on EVX-V1 - TheFly
- 7 days ago - Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 - GlobeNewsWire
- 18 days ago - Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop - GlobeNewsWire
- 5 weeks ago - Evaxion receives Prix Galien UK Award for Best digital health solution - GlobeNewsWire
- 5 weeks ago - Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - GlobeNewsWire
- 2 months ago - Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress - GlobeNewsWire